180 Life Sciences Corp (ATNF)’s stock has witnessed a price hike of 473.03% from the previous close with its current price standing at $8.71. Its current price is -22.30% under its 52-week high of $11.21 and 650.86% more than its 52-week low of $1.16. Based on the past 30-day period, the stock price is -47.16% below the high and +708.51% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, ATNF’s SMA-200 is $2.4542.
How does 180 Life Sciences Corp (ATNF) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 0 brokerage firms that recommend the stock as a Strong Sell. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 0.00 in simple terms.
180 Life Sciences Corp (ATNF): Earnings History
If we examine 180 Life Sciences Corp’s recent earnings history, in the last quarter ended on 9/30/2022, it posted adjusted earnings per share of -$26.6, beating the consensus of $3.8. In other words, it topped the consensus by -$30.4, resulting in a -800.00% surprise. In the 3 months period before the previous quarter which was closed on 9/30/2022, the stock recorded adjusted earnings per share of -$26.6 in contrast with the Outlook of $3.8. That was a difference of -$30.4 and a surprise of -800.00%.
180 Life Sciences Corp (NASDAQ: ATNF) Ownership Details
I will give a breakdown of the key shareholders in 180 Life Sciences Corp (ATNF). Recent figures show that the company’s insiders hold 1.49% of shares. A total of 9 institutional investors hold shares in the company, making 6.39% of its stock and 6.49% of its float.
Jun 30, 2024, it was reported that the Company’s largest institutional holder is Tower Research Capital LLC (TRC) holding total of 6.27 shares that make 0.61% of the company’s total number of shares and are currently priced at 58239.0.
The securities firm Blackrock Inc. holds 772.0 shares of ATNF, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.08%, and the holding percentage of shares is valued at 7171.0.
An overview of 180 Life Sciences Corp’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests 180 Life Sciences Corp (ATNF) traded 3,147,391 shares per day, with a moving average of $1.9589 and price change of +7.3487. With the moving average of $1.9211 and a price change of +7.6487, about 1,293,414 shares changed hands on average over the past 50 days. Finally, ATNF’s 100-day average volume is 1,009,461 shares, alongside a moving average of $1.8886 and a price change of +7.7187.
